carbenoxolone sodium has been researched along with Cardiac Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, PJ; Funder, JW; Morgan, J; Wilson, P; Young, MJ | 1 |
| Dilley, R; Funder, JW; Moussa, L; Young, MJ | 1 |
2 other study(ies) available for carbenoxolone sodium and Cardiac Hypertrophy
| Article | Year |
|---|---|
Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; Carbenoxolone; Cardiomegaly; Endothelium, Vascular; Enzyme Inhibitors; Fibrosis; Macrophages; Male; Myocarditis; Myocardium; Nitric Oxide; Osteopontin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2009 |
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Blood Pressure; Carbenoxolone; Cardiomegaly; Coronary Disease; Desoxycorticosterone; Enzyme Inhibitors; Eplerenone; Fibrosis; Heart; Hydroxysteroid Dehydrogenases; Kidney; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Solutions; Spironolactone; Vasculitis | 2003 |